Status:
COMPLETED
Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Myocardial Ischemia
Coronary Heart Disease
Eligibility:
All Genders
30-80 years
Phase:
PHASE1
PHASE2
Brief Summary
Mesenchymal stem cells from the bone marrow can be stimulated to differentiate into endothelial cells and participate in the development of new blood vessels in ischemic tissue. The aim of the study ...
Detailed Description
Mesenchymal stem cells from the bone marrow can be stimulated to differentiate into endothelial cells and participate in the development of new blood vessels in ischemic tissue. The aim of the study ...
Eligibility Criteria
Inclusion
- Age 30 to 80 years Reversible ischemia on a stress SPECT Angina pectoris CCS class \>\_ 2 Reduced exercise time \< 10 min No further revascularization options
Exclusion
- Pregnant Present or history of cancer Proliferative retinopathy Systemic severe disease LVEF \< 25 % NYHA \> II
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00260338
Start Date
December 1 2005
End Date
July 1 2009
Last Update
May 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Lab. 2014, The Heart Centre, Rigshospitalet, Blegdamcvej 9
Copenhagen, Denmark, 2100